BOX 7-4Policies of American College of Chest Physicians on Industry Funding of Guideline Development

  • Fund development activities are undertaken by the organization’s executive office without the involvement or knowledge by the organizational unit responsible for guideline development, and each guideline ideally is either self-funded or funded by at least three to five outside sources.
  • Names of sponsoring companies are not revealed to staff, society members, and other participants in guideline development until the information is disclosed in the final publication.
  • Sponsors do not nominate topics, participate in meetings, or review drafts. They see the guideline only upon publication.
  • The organization does not inform sponsors of the participants involved in developing a guideline, the specific questions investigated, the methodologists or evidence-based practice center involved in the evidence review, the reviewers, or meeting times or places.
  • Guidelines refer to pharmaceuticals only by their generic names and not by their brand names.

SOURCE: Baumann et al., 2007; Lever and Lewis, 2008.

From: 7, Conflicts of Interest and Development of Clinical Practice Guidelines

Cover of Conflict of Interest in Medical Research, Education, and Practice
Conflict of Interest in Medical Research, Education, and Practice.
Institute of Medicine (US) Committee on Conflict of Interest in Medical Research, Education, and Practice; Lo B, Field MJ, editors.
Washington (DC): National Academies Press (US); 2009.
Copyright © 2009, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.